We'd like to understand how you use our websites in order to improve them. Register your interest. The objective of this study was to develop and manufacture a stable parenteral formulation for Phase I clinical trials of VNPM 1,2-Bis methylsulfonyl 2-chloroethyl [ 2-methylamino carbonyl] hydrazine , a novel antitumor agent. The solubility and stability of the drug was determined.
|Published (Last):||10 March 2017|
|PDF File Size:||6.67 Mb|
|ePub File Size:||15.95 Mb|
|Price:||Free* [*Free Regsitration Required]|
Format: Summary Summary text Abstract Abstract text. Send email Cancel. Add to Collections Create a new collection Add to an existing collection. Name your collection: Name must be less than characters. Choose a collection: Unable to load your collection due to an error Please try again.
Add Cancel. Add to My Bibliography My Bibliography. Unable to load your delegates due to an error Please try again. Your saved search Name of saved search:. Search terms:. Test search terms. Would you like email updates of new search results? Email: change. Frequency: Monthly Weekly Daily. Which day? Send at most: 1 item 5 items 10 items 20 items 50 items items items.
Send even when there aren't any new results. Optional text in email:. Save Cancel. Create a file for external citation management software Create file Cancel. Full-text links Cite Favorites. Similar articles Excipient-drug interactions in parenteral formulations. Akers MJ. J Pharm Sci. PMID: Review. Review of excipients and pH's for parenteral products used in the United States. Wang YC, et al. J Parenter Drug Assoc. PMID: No abstract available. In vitro hemolysis: guidance for the pharmaceutical scientist.
Amin K, Dannenfelser RM. Amin K, et al. PMID: Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use. Holvoet C, et al. Part l. Suspensions and oily solutions for injection]. Pol Merkur Lekarski. Show more similar articles See all similar articles. Cited by 10 articles Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines. Tritama E, et al. Hum Vaccin Immunother.
Epub Feb Insoluble drug delivery strategies: review of recent advances and business prospects. Kalepu S, Nekkanti V. Kalepu S, et al. Acta Pharm Sin B. Epub Aug Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges. Basavaraj S, Betageri GV. Basavaraj S, et al. Epub Jan Considerations in developing a target product profile for parenteral pharmaceutical products.
Lambert WJ. Epub Sep Poly ethyleneglycol dimethylether as novel solvent for injectable in situ forming depots. Schoenhammer K, et al. Pharm Res. Epub Oct 1. Show more "Cited by" articles See all "Cited by" articles. Infusions, Parenteral Actions. Pharmaceutical Solutions Actions. Substances Excipients Actions. Full-text links [x] HighWire.
Compendium of excipients for parenteral formulations.
We'd like to understand how you use our websites in order to improve them. Register your interest. The chemical techniques to solubilize water-insoluble drugs for oral and injection administration include pH adjustment, cosolvents, complexation, microemulsions, self-emulsifying drug delivery systems, micelles, liposomes, and emulsions. This is a preview of subscription content, log in to check access. Rent this article via DeepDyve. Liu ed. Google Scholar.
Solubilizing Excipients in Oral and Injectable Formulations
Compendium of Excipients for Parenteral Formulations
Tags Type your tag names separated by a space and hit enter. Links Publisher Full Text. Nguyen T. Baloian L.